• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

ACP releases clinical practice guidelines for acute gout

byCaitlyn HuiandDeepti Shroff Karhade
November 3, 2016
in Chronic Disease
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. Colchicine, non-steroidal anti-inflammatory drugs (NSAIDs), and corticosteroids were associated with reducing pain in patients with acute gout.

2. Urate-lowering therapies may lower long-term risk for acute gout attacks.    

Evidence Rating Level: 1 (Excellent)

Study Rundown: Gout is one of the most painful forms of arthritis. It is caused by excess crystalized urate deposits in joint fluid, among other related sites, resulting in intermittent periods of synovitis. While gout typically results in acute periods of pain and joint swelling, for some patients, it develops into a chronic condition that can largely impede their lives. The authors of this study sought to review evidence regarding management of gout to prevent attacks in order to support the development of clinical practice guidelines. Collectively, they observed that colchicine, NSAIDs, and corticosteroids relieve pain in adults with acute gout. Furthermore, lower urate levels reduce the risk for recurrent acute gout attacks. This study has several limitations. First, there were no placebo-controlled trials of management of hyperuricemia that lasted longer than 6 months. In addition, only 10 studies clearly stated that patients came exclusively from primary care sites; therefore, the authors judged the evidence to only be moderately applicable to primary care. Overall, the results of this study may be used to form key guidelines to improve future management of gout.

Click to read the study in the Annals of Internal Medicine

Relevant Reading: 2016 updated EULAR evidence-based recommendations for the management of gout.

In-Depth [systematic review]: The authors followed the PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) guidelines in designing their methodology. They searched for systematic reviews and original research studies in PubMed, EMBASE, the Cochrane Collaboration, and the Web of Science utilizing the terms “gout” and “gouty.” In total, 155 relevant articles were identified as meeting the inclusion criteria and were included for data analysis. As mentioned, a key finding of this systematic review is that there is high-strength evidence to suggest that colchicine, NSAIDs, and corticosteroids help reduce symptoms in patients with acute gout. In contrast, insufficient evidence was found to suggest that monitoring serum urate levels improves outcomes. Low-strength evidence also existed to support that treating to a specific target serum urate level would reduce the risk for gout attacks.

RELATED REPORTS

Allopurinol does not reduce cardiovascular risk for patients with ischemic heart disease without gout

Gout flares associated with a transient increase in subsequent risk of cardiovascular events

Allopurinol does not increased mortality in gout and chronic kidney disease patients

Image: CC/Wiki

©2016 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: gout
Previous Post

Systematic review suggests synovial fluid analysis when necessary for diagnosis of gout

Next Post

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation

RelatedReports

Cardiology

Allopurinol does not reduce cardiovascular risk for patients with ischemic heart disease without gout

October 18, 2022
Increased diabetes risk observed in gout patients
Cardiology

Gout flares associated with a transient increase in subsequent risk of cardiovascular events

August 8, 2022
Increased diabetes risk observed in gout patients
Chronic Disease

Allopurinol does not increased mortality in gout and chronic kidney disease patients

February 8, 2022
Implementation of pneumococcal vaccine programs linked to decreased antibiotic prescription
Chronic Disease

Use of sodium-glucose transport protein 2 inhibitors associated with lowered incidence of gout in patients with type 2 diabetes

November 23, 2021
Next Post
Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation

Sleep duration, sleepiness, chronotype have variable associations with teen self-regulation

Late gestation antidepressant use linked to postpartum hemorrhage

Antiretroviral therapy lowers mother-to-child HIV transmission rates

Hepatitis C screening in prisons may reduce transmission and infection rates

Psychotropic medications reduce further violent crimes in released prisoners

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Active surveillance strategies to improve rates of inferior vena cava filter retrieval
  • Intranasal vaccine against Bordetella pertussis invokes seronegative IgA response
  • Hydrochlorothiazide does not impact risk of kidney-stone recurrence
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options